Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.

Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.

Endocrine and Targeted Therapy for Hormone-Receptor-Positive, HER2-Negative Advanced Breast Cancer: Insights to Sequencing Treatment and Overcoming Resistance Based on Clinical Trials.

Autor: El Sayed R; Oncology Division, Department of Internal Medicine, American University of Beirut Medical Center, American University of Beirut, Beirut, Lebanon., El Jamal L; School of Medicine, American University of Beirut, Beirut, Lebanon., El Iskandarani S; School of Medicine, American University of Beirut, Beirut, Lebanon., Kort J; Oncology Division, Department of Internal Medicine, American University of Beirut Medical Center, American University of Beirut, Beirut, Lebanon., Abdel Salam M; School of Medicine, American University of Beirut, Beirut, Lebanon., Assi H; Oncology Division, Department of Internal Medicine, American University of Beirut Medical Center, American University of Beirut, Beirut, Lebanon.

Publikováno v: Frontiers in oncology [Front Oncol] 2019 Jun 21; Vol. 9, pp. 510. Date of Electronic Publication: 2019 Jun 21 (Print Publication: 2019).